Bone remodelation markers are useful in the management of monoclonal gammopathies.
Hernández JM, Suquía B, Queizan JA, Fisac RM, Sanchez JJ, Fernández-Calvo FJ, García-Sanz R, Olivier C, Bárez A, Calmuntia MJ, García-Frade J, Portero JA, López R, Aguilera C, Navajo JA, San-Miguel JF.
Hernández JM, et al. Among authors: san miguel jf.
Hematol J. 2004;5(6):480-8. doi: 10.1038/sj.thj.6200564.
Hematol J. 2004.
PMID: 15570289
Clinical Trial.